Stocksigma LogoStocksigma Logo

Counter Cyclical Investments Crosses 5% Stake in Jenburkt Pharmaceuticals

Counter Cyclical Investments Private Limited acquired 326 equity shares (0.01% stake) in Jenburkt Pharmaceuticals Ltd via an open-market transaction on 9th

Counter Cyclical Investments Crosses 5% Stake in Jenburkt Pharmaceuticals

Jenburkt Pharmaceuticals Ltd 路 Acquisition/ Disposal of Shares 路 12 Oct 2026, 11:11 pm

Counter Cyclical Investments Crosses 5% Stake in Jenburkt Pharmaceuticals Counter Cyclical Investments Private Limited acquired 326 equity shares (0.01% stake) in Jenburkt Pharmaceuticals Ltd via an open-market transaction on 9th Oct'26. Following this acquisition on behalf of its PMS clients, the acquirer's aggregate holding increased from 2,20,605 shares (4.99%) to 2,20,931 shares, crossing the statutory 5% threshold to reach 5.01% of the company's total paid-up equity share capital of 44,13,300 shares. Consequently, disclosures were submitted under Regulation 29(1) of SEBI SAST Regulations, 2011.

Original exchange filing (PDF)

More announcements from Jenburkt Pharmaceuticals Ltd

All Jenburkt Pharmaceuticals Ltd announcements